chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 50.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site pain
Clinical narrative: This case was reported by a consumer via sales rep and described the occurrence of injection site pain in a 50-year-old female patient who received SHINGRIX (batch number XC534, expiry date 4th July 2020). On 5th February 2018, the patient received the 1st dose of SHINGRIX. On 5th February 2018, less than a day after receiving SHINGRIX, the patient experienced injection site pain. In February 2018, the outcome of the injection site pain was recovered/resolved. The reporter considered the injection site pain to be probably related to SHINGRIX. Additional details were provided as follows: The patient received SHINGRIX in the left deltoid. Pain at the injection site lasted for 3 days. For tolerability after receiving 2nd dose of SHINGRIX, refer case US2018GSK081832.
Age: 88.0
Sex: F
Vaccine: VARZOS
Symptoms: Injected limb mobility decreased, Injection site discomfort, Myalgia
Clinical narrative: This case was reported by a pharmacist via call center representative and described the occurrence of injection site discomfort in a 88-year-old female patient who received SHINGRIX (batch number ZY3X4, expiry date 28th April 2020). Concomitant products included Metoprolol succinate. On 27th April 2018, the patient received the 1st dose of SHINGRIX (intramuscular) .5 ml. On 27th April 2018, less than a day after receiving SHINGRIX, the patient experienced injection site discomfort. On 1st May 2018, the patient experienced muscle soreness and injected limb mobility decreased. On an unknown date, the outcome of the injection site discomfort, muscle soreness and injected limb mobility decreased were not recovered/not resolved. The reporter considered the injection site discomfort and muscle soreness to be probably related to SHINGRIX. It was unknown if the reporter considered the injected limb mobility decreased to be related to SHINGRIX. Additional details were reported as follows: The patient experienced mild arm discomfort at the injection site. Four days after receiving SHINGRIX, the patient developed a sore muscle and it was hard to lift her arm.
Sex: U
Vaccine: VARZOS
Symptoms: Adverse reaction
Clinical narrative: This case was reported by a pharmacist via call center representative and described the occurrence of adverse reaction in a adult patient who received SHINGRIX. On an unknown date, the patient received the 1st dose of SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced adverse reaction. On an unknown date, the outcome of the adverse reaction was unknown. It was unknown if the reporter considered the adverse reaction to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The patient developed a big reaction after receiving SHINGRIX. The healthcare professional (HCP) reported that the adverse reaction as reported to her from a colleague, however no further details of the exact reaction or further patient information was provided to HCP about the event. The HCP reported, she could obtain further details and provide them as follow up report as a later time. No further information was available regarding the event at this time.
Age: 61.0
Sex: F
Vaccine: VARZOS
Symptoms: Headache, Pain in extremity
Clinical narrative: This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a 61-year-old female patient who received SHINGRIX. On 1st May 2018, the patient received the 1st dose of SHINGRIX (intramuscular). On 1st May 2018, less than an hour after receiving SHINGRIX, the patient experienced pain in arm. On 2nd May 2018, the patient experienced headache. On an unknown date, the outcome of the pain in arm and headache were not recovered/not resolved. The reporter considered the pain in arm and headache to be related to SHINGRIX. Additional information was received as follows: The patient did not have any concomitant medications. The reporter stated that she got a dose of SHINGRIX, the day before the reporting date in left arm. The patient was expected to have the soreness, which she got within an hour of the shot. But in morning, on the day of reporting (1 day after vaccination), the patient woke up with a terrible headache and added she didn't get headaches usually. The patient was provided the information from the prescribing information and referred to her physician.
Sex: M
Vaccine: VARZOS
Symptoms: Hypersensitivity, Pruritus, Tachycardia, Urticaria, Vomiting
Clinical narrative: This case was reported by a consumer via other and described the occurrence of allergic reaction in a male patient who received SHINGRIX (batch number B327C, expiry date unknown). On 25th April 2018, the patient received SHINGRIX. On an unknown date, less than a month after receiving SHINGRIX, the patient experienced allergic reaction, pruritus, welts, vomiting and tachycardia. On an unknown date, the outcome of the allergic reaction, pruritus, welts, vomiting and tachycardia were unknown. It was unknown if the reporter considered the allergic reaction, pruritus, welts, vomiting and tachycardia to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The patient allegedly had SHINGRIX vaccination on 25th April 2018 and had allergic reaction resulting in itching, welts, vomiting and tachycardia. The medical attention was being sought.
Sex: U
Vaccine: VARZOS
Symptoms: Influenza like illness
Clinical narrative: This case was reported by a consumer and described the occurrence of influenza-like symptoms in an unspecified number of adult patients who received SHINGRIX. On an unknown date, the patient received SHINGRIX at an unknown dose. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced influenza-like symptoms. On an unknown date, the outcome of the influenza-like symptoms was unknown. It was unknown if the reporter considered the influenza-like symptoms to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not applicable for this report. An unspecified number of patients experienced flu-like symptoms. The reporter stated the SHINGRIX vaccination was beyond worth to be protected from the shingles. The reporter could not be contacted. This case is 1 of 4 cases, reported by the same reporter.
Sex: M
Vaccine: VARZOS
Symptoms: Adverse drug reaction, Therapeutic response unexpected
Clinical narrative: This case was reported by a consumer via call center representative and described the occurrence of adverse drug reaction in a male patient who received SHINGRIX. On 21st April 2018, the patient received the 1st dose of SHINGRIX. On an unknown date, less than a month after receiving SHINGRIX, the patient experienced adverse drug reaction and unexpected therapeutic effect. On an unknown date, the outcome of the adverse drug reaction and unexpected therapeutic effect were unknown. It was unknown if the reporter considered the adverse drug reaction and unexpected therapeutic effect to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The patient received SHINGRIX at the local pharmacy. For the next few days, the patient experienced the expected side effects (not specified) of the immunization to varied degrees. On Monday (not specified), after receiving SHINGRIX, while commuting on public transportation, the patient noticed that the left knee pain which he always had on walking up a flight of stairs was gone. The patient figured he had a good day. Almost two weeks had past and the patient was completely pain free in the knee that had been problem for at least five years. The patient reported that, the pain initially was extreme on walking but that was solved with isometric exercise and avoiding the direct air conditioning vent airflow while sleeping. The slight pain while climbing stairs was controlled by holding on to the banisters and walking up a little more carefully and slowly. Now after receiving SHINGRIX, that was all unnecessary and the patient had no pain, which led to unexpected therapeutic effect. The patient stated it made no sense why a shingles vaccine would have this effect, but it had and the patient would like to talk to someone about this very positive side effect.
Sex: F
Vaccine: VARZOS
Symptoms: Incorrect route of drug administration, Injection site erythema, Injection site pruritus, Injection site rash, Injection site swelling
Clinical narrative: This case was reported by a physician via sales rep and described the occurrence of injection site itching in a female patient who received SHINGRIX. On an unknown date, the patient received SHINGRIX (subcutaneous). On an unknown date, less than a week after receiving SHINGRIX, the patient experienced injection site itching, injection site erythema, injection site swelling, injection site rash and intramuscular formulation administered by other route. On an unknown date, the outcome of the injection site itching, injection site erythema, injection site swelling, injection site rash and intramuscular formulation administered by other route were unknown. The reporter considered the injection site itching, injection site erythema, injection site swelling and injection site rash to be related to SHINGRIX. Additional information was received as follows: The call center representative was attending SHINGRIX program on 3rd May 2018. The physician reported the events experienced by the patient who had received SHINGRIX vaccine. The caller stated that the reporter did not want to be contacted regarding this report. The caller stated that the reporter noted that the patient within the last few days had gone to a pharmacy to receive SHINGRIX shot. The reporter thought that the patient was given the vaccine subcutaneously instead of intramuscularly, which led to inappropriate route of vaccine administration. The caller stated that the reporter noted that the patient also developed a very swollen arm, rash, redness and itching at and around the injection site. The caller stated that the reporter instructed the patient to put ice pack on the arm and use TYLENOL and ADVIL as needed. The caller stated it was unknown if these events had resolved. The caller stated that no additional details were available.
Sex: M
Vaccine: VARZOS
Symptoms: Malaise
Clinical narrative: This case was reported by a consumer and described the occurrence of sickness in a adult male patient who received SHINGRIX. On an unknown date, the patient received SHINGRIX at an unknown dose. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced sickness. On an unknown date, the outcome of the sickness was unknown. It was unknown if the reporter considered the sickness to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The patient got sick. The reporter stated the SHINGRIX vaccination was beyond worth to be protected from the shingles. The reporter could not be contacted. This case is 1 of 4 cases, reported by the same reporter.
Sex: U
Vaccine: VARZOS
Symptoms: Mobility decreased, Myalgia, Pain in extremity, Peripheral swelling
Clinical narrative: This case was reported by a consumer via sales rep and described the occurrence of pain in arm in a 73-year-old patient who received SHINGRIX. On an unknown date, the patient received the 1st dose of SHINGRIX. In April 2018, less than a year after receiving SHINGRIX, the patient experienced pain in arm, swelling arm, mobility decreased and myalgia. On an unknown date, the outcome of the pain in arm, swelling arm, mobility decreased and myalgia were not recovered/not resolved. It was unknown if the reporter considered the pain in arm, swelling arm, mobility decreased and myalgia to be related to SHINGRIX. Additional information was received as follows: The age at vaccination could be 72 years or 73 years or 74 years. The pharmacist said that it could take 7 days to feel better to the patient because of the patient's age. The patient was looking at two weeks of myalgia so far.
Age: 50.0
Sex: F
Vaccine: VARZOS
Symptoms: Abdominal discomfort, Contusion, Fatigue, Headache, Pain in extremity
Clinical narrative: This case was reported by a consumer via sales rep and described the occurrence of upset stomach in a 50-year-old female patient who received SHINGRIX (batch number XC534, expiry date 4th July 2020. Concomitant products included SHINGRIX. On 21st April 2018, the patient received the 2nd dose of SHINGRIX. On 22nd April 2018, 1 days after receiving SHINGRIX, the patient experienced upset stomach, fatigue, contusion and headache. On an unknown date, the patient experienced pain in arm. On an unknown date, the outcome of the upset stomach, fatigue, contusion, headache and pain in arm were recovering/resolving. The reporter considered the upset stomach, fatigue, contusion, headache and pain in arm to be probably related to SHINGRIX. Additional details were provided as follows: For tolerability after receiving 2nd dose of SHINGRIX, refer case US2018078793. The age at vaccination was not reported. The patient received SHINGRIX in the left deltoid. The patient experienced bruising after vaccination. Less than a month after receiving vaccination, the patient experienced arm pain. The expiry date was reported as 4th July 2018 and was corrected to 4th July 2020 as per sales database.
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster
Clinical narrative: This case was reported by a other health professional via call center representative and described the occurrence of shingles in a adult patient who received SHINGRIX. On an unknown date, the patient received the 1st dose of SHINGRIX .5 ml. On an unknown date, 14 days after receiving SHINGRIX, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown. The reporter considered the shingles to be unrelated to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. Approximately two weeks after the vaccination the patient was diagnosed with shingles by a dermatologist. The caller stated that no demographics for the patient were available. The caller stated that the reporter noted that the patient's primary care physician and dermatologist did not relate the SHINGRIX dose to the event. The caller provided the patient's primary care physician information.
Sex: U
Vaccine: VARZOS
Symptoms: Injection site pain
Clinical narrative: This case was reported by a nurse via sales rep and described the occurrence of injection site pain in a adult patient who received SHINGRIX. On an unknown date, the patient received SHINGRIX at an unknown dose. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced injection site pain. On an unknown date, the outcome of the injection site pain was unknown. It was unknown if the reporter considered the injection site pain to be related to SHINGRIX. Additional information was received as follows: The age at vaccination was not reported.
Sex: M
Vaccine: VARZOS
Symptoms: Malaise
Clinical narrative: This case was reported by a consumer and described the occurrence of feeling unwell in a male patient who received SHINGRIX. On an unknown date, the patient received SHINGRIX at an unknown dose. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced feeling unwell. On an unknown date, the outcome of the feeling unwell was unknown. It was unknown if the reporter considered the feeling unwell to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The patient experienced sickness. The reporter stated the SHINGRIX vaccination was beyond worth to be protected from the shingles. The reporter could not be contacted. This case is 1 of 4 cases, reported by the same reporter.
Age: 65.0
Sex: F
Vaccine: VARZOS
Symptoms: Herpes zoster
Clinical narrative: This case was reported by a consumer via call center representative and described the occurrence of shingles in a 65-year-old female patient who received SHINGRIX. Co-suspect products included ENBREL for an unknown indication. The patient's past medical history included rheumatoid arthritis. Concomitant products included methotrexate, cyclobenzaprine and tramadol. On 25th March 2018, the patient received the 1st dose of SHINGRIX. On an unknown date, the patient started ENBREL at an unknown dose and frequency. On 2nd May 2018, 38 days after receiving SHINGRIX, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown. The reporter considered the shingles to be unrelated to SHINGRIX. Additional information was received as follows: The patient reported that she diagnosed herself with shingles. It had not been confirmed by a health care professional. The patient was not taking ENBREL for a few months and that ENBREL was not being taken during the vaccination due to affordability. The patient began taking ENBREL again just prior the shingles, with no specific restart date. The patient felt that she was already immunosuppressed and that the ENBREL caused her shingles. The patient had denied permission to contact their physician.
Sex: U
Vaccine: VARZOS
Symptoms: Pain in extremity
Clinical narrative: This case was reported by a consumer and described the occurrence of pain in arm in an unspecified number of adult patients who received SHINGRIX. On an unknown date, the patient received SHINGRIX at an unknown dose. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was unknown. It was unknown if the reporter considered the pain in arm to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not applicable for this report. An unspecified number of patients experienced arm soreness. The reporter stated the SHINGRIX vaccination was beyond worth to be protected from the shingles. The reporter could not be contacted. This case is 1 of 4 cases, reported by the same reporter.
Age: 75.0
Sex: F
Vaccine: VARZOS
Symptoms: Chills, Fatigue, Pain in extremity, Pyrexia, Urticaria
Clinical narrative: This case was reported by a consumer via call center representative and described the occurrence of chills in a 75-year-old female patient who received SHINGRIX. Concurrent medical conditions included blood pressure high, blood cholesterol increased and thyroid disorder. Concomitant products included Levothyroxine. On 25th April 2018, the patient received the 1st dose of SHINGRIX. In April 2018, less than a week after receiving SHINGRIX, the patient experienced pain in arm. On 25th April 2018, the patient experienced chills and fever. On 26th April 2018, the patient experienced exhaustion. On 27th April 2018, the patient experienced welts. The patient was treated with Aspirin. In April 2018, the outcome of the chills was recovered/resolved. On 26th April 2018, the outcome of the fever was recovered/resolved. On 27th April 2018, the outcome of the exhaustion was recovered/resolved. On an unknown date, the outcome of the pain in arm and welts were recovered/resolved. It was unknown if the reporter considered the chills, pain in arms, welts, fever and exhaustion to be related to SHINGRIX. Additional details were provided as follows: Reporter was the patient. At 11:30 hours, the patient received SHINGRIX. At 23:30 hours, the patient experienced chills on the night she received vaccine and resolved within approximately 1.5 hours. The patient experienced fever on the date of vaccination, no temperature was recorded and the fever resolved next morning. Reporter could not provide lot number or expiration date of SHINGRIX. The patient described exhaustion as feeling exhausted while sitting in a chair, and spending most of the day in bed. The patient described welt which was located approximately 6 inches below injection site approximately 3 inches wide and wrapped around the side of the left arm. Welt was hot, swollen, and painful. The patient sought care at urgent care for the welt and was advised to monitor only. Welt resolved approximately 2 days later, no exact date provided. The event sore arm resolved either 30th April 2018 or 1st May 2018, she could not specified.
Age: 65.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site pain
Clinical narrative: This case was reported by a pharmacist via call center representative and described the occurrence of injection site tenderness in a 65-year-old female patient who received SHINGRIX. On 1st May 2018, the patient received the 2nd dose of SHINGRIX. In May 2018, less than a week after receiving SHINGRIX, the patient experienced injection site tenderness and injection site erythema. On an unknown date, the outcome of the injection site tenderness and injection site erythema were unknown. It was unknown if the reporter considered the injection site tenderness and injection site erythema to be related to SHINGRIX. Additional information was received as follows: The patient experienced tenderness, redness, and softball size circle at injection site. The patient did not have further details. The vaccine was administered at another site (place).
Sex: M
Vaccine: VARZOS
Symptoms: Chills, Headache, Incorrect route of drug administration
Clinical narrative: This case was reported by a pharmacist via call center representative and described the occurrence of shivering in a adult male patient who received SHINGRIX (batch number YS53Y, expiry date unknown). On an unknown date, the patient received SHINGRIX (subcutaneous). On an unknown date, less than a year after receiving SHINGRIX, the patient experienced shivering, headache and intramuscular formulation administered by other route. On an unknown date, the outcome of the shivering, headache and intramuscular formulation administered by other route were unknown. It was unknown if the reporter considered the shivering and headache to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The patient inadvertently received SHINGRIX subcutaneously instead of intramuscularly, which led to intramuscular formulation administered by other route. The reporter was unable to provide the expiration date of the SHINGRIX because the system defaulted to 1 year from administration. On 3rd May 2018, the reporter was contacted via phone for the medical information. It was an accidental medication error with adverse event. The pharmacist did not have any additional details.
Sex: F
Vaccine: VARZOS
Symptoms: Herpes zoster
Clinical narrative: This case was reported by a pharmacist via call center representative and described the occurrence of shingles in a adult female patient who received SHINGRIX. On 18th April 2018, the patient received the 1st dose of SHINGRIX. On 30th April 2018, 12 days after receiving SHINGRIX, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown. It was unknown if the reporter considered the shingles to be related to SHINGRIX. Additional information was received as follows: The age at vaccination was not reported. The reporter said that she wanted to check with the patient first to get permission to give any more information. No further information was provided.
Age: 51.0
Sex: F
Vaccine: VARZOS
Symptoms: Headache, Lip blister, Pruritus, Pyrexia, Rash
Clinical narrative: This case was reported by a pharmacist via call center representative and described the occurrence of headache in a 51-year-old female patient who received SHINGRIX (batch number 9AS39, expiry date 20th July 2020). On 26 April 2018, the patient received the 1st dose of SHINGRIX. On 27th April 2018, 1 days after receiving SHINGRIX, the patient experienced headache, lip blister, rash, fever and pruritus. The patient was treated with ZYRTEC and triamcinolone. On an unknown date, the outcome of the headache, lip blister, rash, fever and pruritus were unknown. It was unknown if the reporter considered the headache, lip blister, rash, fever and pruritus to be related to SHINGRIX. Additional information was received as follows: On 26th April 2018 at 15:00, the patient received SHINGRIX on left deltoid. The patient experienced the rash all over her waist, arms, legs and thighs. The pharmacist had not follow-up with the patient since, so was not sure if the symptoms had resolve.
Age: 41.0
Sex: M
Vaccine: HEPA
Symptoms: Hypoaesthesia, Injected limb mobility decreased, Injection site pain
Clinical narrative: This case was reported by a pharmacist via call center representative and described the occurrence of injection site pain in a 41-year-old male patient who received HAVRIX 1440 (batch number PZ353, expiry date 21st November 2020). On 2nd May 2018, the patient received the 1st dose of HAVRIX 1440. On 2nd May 2018, less than a day after receiving HAVRIX 1440, the patient experienced injection site pain, injected limb mobility decreased and numbness in fingers. On an unknown date, the outcome of the injection site pain, injected limb mobility decreased and numbness in fingers were unchanged. The reporter considered the injection site pain, injected site limb mobility decreased and numbness in fingers to be almost certainly related to HAVRIX 1440. Additional information was received as follows: The patient received HAVRIX 1440 on the left arm. The patient experienced arm pain and difficulty in raising the arm.
Age: 50.0
Sex: F
Vaccine: VARZOS
Symptoms: Dizziness, Peripheral swelling
Clinical narrative: Lightheaded, arm swelling-got MEDROL DOSE PAK from Dr.
Age: 68.0
Sex: F
Vaccine: PNC13
Symptoms: Erythema, Pyrexia, Skin warm, Swelling, Tenderness
Clinical narrative: Large 10cm area of erythema hot to touch moderate swelling and mild TTP no induration or fluctuance. Increased in size gradually. Low grade fever 99.0 tympanic. Diagnosed with cellulitis. treated with BACTRIM DS 800-160mg tabs, one tab BID, DIPHENHIST 25mg one tab every 6 hrs as needed.
Age: 71.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site rash, Injection site swelling
Clinical narrative: Patient reports developing a rash/raised bump at injection site on night of vaccination. Called the pharmacy two days later and reported that the rash and slightly worsened. Did not experience any other adverse reactions.
Age: 79.0
Sex: F
Vaccine: PNC13
Symptoms: Injection site pruritus, Injection site rash, Injection site warmth
Clinical narrative: Patient reported to the pharmacy last night saying that she had a large rash on her right upper arm beginning at the injection site and moving down to her elbow. Patient stated that the rash began on Wednesday and was hot and slightly itchy. Advised patient to take over the counter benadryl and call us back on 5/12/18 to let us know how she was doing.
Age: 60.0
Sex: M
Vaccine: VARZOS
Symptoms: Chills, Cough, Fatigue, Headache, Malaise
Clinical narrative: General malaise beginning evening of vaccination. Patient was unable to leave bed for 3 days. No rash. Fever, fatigue, chills, nausea, headache, and a cough. Patient experienced adverse reaction after receiving first vaccination as well. Aching from head to toe.
Age: 60.0
Sex: M
Vaccine: VARZOS
Symptoms: Nausea, Pain, Pyrexia
Clinical narrative: General malaise beginning evening of vaccination. Patient was unable to leave bed for 3 days. No rash. Fever, fatigue, chills, nausea, headache, and a cough. Patient experienced adverse reaction after receiving first vaccination as well. Aching from head to toe.
Age: 66.0
Sex: F
Vaccine: VARZOS
Symptoms: Haematoma, Inflammation, Peripheral swelling, Skin discolouration
Clinical narrative: Approximately one hour after vaccination a hematoma formed just above the elbow. It appears black and blue about 2 inches across. It was originally very puffy but it has decreased in size, but is still inflamed. Color has gone unchanged.
Age: 76.0
Sex: F
Vaccine: VARZOS
Symptoms: Asthenia, Headache, Myalgia, Pyrexia
Clinical narrative: Received shot on 5/11/2018. Woke up next morning feeling muscle pain, headache, fever and weak.
Age: 11.0
Sex: M
Vaccine: MNQ
Symptoms: Erythema, Peripheral swelling
Clinical narrative: Whole upper left arm swollen and red.
Age: 60.0
Sex: F
Vaccine: TDAP, VARZOS
Symptoms: Headache, Pain, Pyrexia
Clinical narrative: Fever of 101.7, headache, body aches.
Age: 60.0
Sex: F
Vaccine: VARZOS
Symptoms: Dizziness, Oxygen saturation decreased, Palpitations, Pneumonia, Pyrexia
Clinical narrative: Several Days of High fever of 104.6, red rash on left side of body, dizziness, Heart palpitation, low oxygen, pneumonia.
Age: 60.0
Sex: F
Vaccine: VARZOS
Symptoms: Rash erythematous
Clinical narrative: Several Days of High fever of 104.6, red rash on left side of body, dizziness, Heart palpitation, low oxygen, pneumonia.
Age: 86.0
Sex: F
Vaccine: VARZOS
Symptoms: Dizziness, Headache, Nausea
Clinical narrative: LIGHTHEADED, DIZZINESS, HEADACHE, NAUSEA,.
Age: 65.0
Sex: M
Vaccine: PNC13
Symptoms: Injection site pain
Clinical narrative: Patient reports tenderness and soreness at injection site. It started the day vaccine was administered and has persisted. He stated the pain is not severe and he is able to move his arm and lift objects, but it feels sore and tender when touched. He was advised to contact his Dr. if pain persists or worsens.
Age: 51.0
Sex: F
Vaccine: VARZOS
Symptoms: Fatigue, Headache, Pain
Clinical narrative: Exhaustion/fatigue, headache, body pains/aches including feet - set in the morning following the vaccinations (approximately 12 hours after) - symptomatic treatment  - recommended TYLENOL/ibuprofen for headache/body aches.
Age: 1.25
Sex: F
Vaccine: DTAPIPVHIB
Symptoms: Swelling face, Urticaria
Clinical narrative: Developed urticaria and facial swelling several hours after the vaccine was given.
Age: 60.0
Sex: F
Vaccine: VARZOS
Symptoms: Arthralgia, Headache, Musculoskeletal stiffness, Nausea, Pain of skin
Clinical narrative: Severe arm stiffness, nausea, headache, skin pain, joint pain beginning morning after vaccine requiring patient to rest for 2 days. Has seen gradual improvement in symptoms since, and is still recovering.
Age: 61.0
Sex: M
Vaccine: VARZOS
Symptoms: Injection site mass, Injection site swelling
Clinical narrative: Within a minute of administering the vaccine the patient developed swelling at the site about one inch in diameter. There is a visible lump at the injection site. Patient had no other symptoms. Gave patient 50mg of diphenhydramine and monitored blood pressure and pulse. Both were normal.
Age: 77.0
Sex: F
Vaccine: TDAP
Symptoms: Oropharyngeal pain, Speech disorder
Clinical narrative: Patient reported extremely sore throat to the point where she can't talk, starting Friday, May 11th.
Age: 60.0
Sex: F
Vaccine: VARZOS
Symptoms: Arthralgia, Chills, Contusion, Pain, Pain in extremity
Clinical narrative: Pt experienced "ache" in the ankle and toes at 5am the following morning (after receiving vaccine). It continued throughout the day to general body ache. At 3pm she started to get low grade fever (100.1F) and chills. Her arm was painful and bruised.
Age: 60.0
Sex: F
Vaccine: VARZOS
Symptoms: Pyrexia
Clinical narrative: Pt experienced "ache" in the ankle and toes at 5am the following morning (after receiving vaccine). It continued throughout the day to general body ache. At 3pm she started to get low grade fever (100.1F) and chills. Her arm was painful and bruised.
Age: 70.0
Sex: F
Vaccine: VARZOS
Symptoms: Fatigue, Headache, Injection site pain, Pyrexia, Vomiting
Clinical narrative: Pain at site of shot; feeling tired; headache; vomiting; fever. From 5/10 through 5/11/2018. Tiredness, headache, vomiting and fever subsided by 11PM on 5/12/18 after taking 325 mg TYLENOL every 4 hours.
Age: 71.0
Sex: F
Vaccine: VARZOS
Symptoms: Erythema, Pruritus, Urticaria
Clinical narrative: Redness, pruritis, urticaria.
Age: 56.0
Sex: F
Vaccine: VARZOS
Symptoms: Rash, Rash pruritic, Scab
Clinical narrative: Rash across entire back, very itchy and led to scabbing. Finally healed after 1 month.
Age: 70.0
Sex: M
Vaccine: VARZOS
Symptoms: Biopsy skin, Rash
Clinical narrative: On May 8, 2018 the patient came in to the pharmacy where he received his SHINGRIX shot and inquired if the rash he developed a few days before was shingles and he was referred to his primary care physician.
Age: 54.0
Sex: F
Vaccine: VARZOS
Symptoms: Headache, Influenza like illness, Pyrexia
Clinical narrative: Patient noticed a fever as high as 101 degrees, in addition to headache and other flu like symptoms. She didn't go into much specifics and stated that she plans to get the second shot in the series to complete her prevention steps for avoidance of shingles. She had also suffered similar injection site challenges when she received ZOSTAVAX in the past.
Age: 5.0
Sex: F
Vaccine: DTAPIPV
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth
Clinical narrative: Localized redness, warmth, and swelling to the surrounding area of injection.
Age: 0.25
Sex: F
Vaccine: IPV, UNK
Symptoms: Rash, Urticaria
Clinical narrative: Severe hives/rash 4 days after MMR and polio given. I don't even know for sure which kind of MMR was given-the MMR II or PROQUAD with varicella. Both MMR and Polio shots are contraindicated in shots system because of certified immunity through titers testing. Father ignored shot record form and health care provider did too, but father refuses to disclose name of health care provider. The shots were not given at our daughter's doctor. I am following directions from Dr. BENADRYL is helping but 3 hours later patient is still recovering and not 100% better. Patient never breaks out like this.
Age: 78.0
Sex: M
Vaccine: HEPA
Symptoms: Blister, Decreased appetite, Fatigue, Nausea, Pyrexia
Clinical narrative: Fatigue, nausea, vomiting, loss of appetite, fever, blisters.
Age: 78.0
Sex: M
Vaccine: HEPA
Symptoms: Vomiting
Clinical narrative: Fatigue, nausea, vomiting, loss of appetite, fever, blisters.
Age: 71.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Erythema, Pain, Skin warm, Swelling
Clinical narrative: SORE, RED AND SLIGHTLY SWOLLEN, WARM TO THE TOUCH.
Age: 71.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Injection site erythema, Injection site pain, Injection site scar, Injection site swelling, Injection site warmth
Clinical narrative: SORE, RED AND SLIGHTLY SWOLLEN, WARM TO THE TOUCH.
Age: 71.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Pain, Pyrexia
Clinical narrative: SORE, RED AND SLIGHTLY SWOLLEN, WARM TO THE TOUCH.
Age: 67.0
Sex: F
Vaccine: VARZOS
Symptoms: Abdominal discomfort, Body temperature increased, Injection site mass, Injection site pruritus, Nausea
Clinical narrative: Nauseam low grade temp, itchy at site, 3" lump at site, stomach upset.
Age: 64.0
Sex: F
Vaccine: VARZOS
Symptoms: Chills, Fatigue, Nausea, Tremor
Clinical narrative: Experienced violent shaking, not just shivers, violent teeth shattering shaking for 3 hours. Woke up the next day feeling exhausted and sick to my stomach. By 10:30 I was fine.
Age: 67.0
Sex: M
Vaccine: VARZOS
Symptoms: Abdominal pain upper, Headache, Impaired driving ability, Influenza, Malaise
Clinical narrative: Severe flu, violent shaking, 101 fever, stomach ache, headache. Did I say severe flu. So sick, I couldn't drive myself to the ER. Took 3 days to act normal.
Age: 67.0
Sex: M
Vaccine: VARZOS
Symptoms: Pyrexia, Tremor
Clinical narrative: Severe flu, violent shaking, 101 fever, stomach ache, headache. Did I say severe flu. So sick, I couldn't drive myself to the ER. Took 3 days to act normal.
Age: 72.0
Sex: M
Vaccine: VARZOS
Symptoms: Erythema, Injection site pain, Pain in extremity
Clinical narrative: First 3 days problem arm. 3 in circle of pain - red and sore. Extended soreness at injection site for 6 days after injection.
Age: 75.0
Sex: F
Vaccine: VARZOS
Symptoms: Allergy to metals, Pain, Swelling
Clinical narrative: Swelling and pain due to allergy to thimerosal preservative. I dread receiving the 2nd SHINGRIX vaccination.
Age: 15.0
Sex: M
Vaccine: TDAP
Symptoms: Abdominal pain, Headache, Pyrexia
Clinical narrative: Fever to 102, headache, abdominal pain starting 7 am day after vaccine. Symptomatic support - TYLENOL, IBU prn, push fluids OTC,
Age: 71.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site irritation, Injection site swelling, Injection site warmth
Clinical narrative: Pt arrived at pharmacy on 5/11/18 displaying redness, swelling and irritation at site of injection and surrounding area. Area was about 2 inches wide by 4 inches long, and pt said area was warm to the touch on the left arm.
Age: 70.0
Sex: F
Vaccine: VARZOS
Symptoms: Pain, Pain in extremity, Skin warm
Clinical narrative: 3 inch circle of pain. Intense pain for 4 days. Moving arm was very painful and warm. Relief after 1 week.
Age: 27.0
Sex: F
Vaccine: TDAP
Symptoms: Exposure during pregnancy, Fatigue, Injection site erythema, Injection site induration, Injection site pain
Clinical narrative: My pregnancy has been going perfect. Symptoms since the shot -pain where the shot was given -redness and swelling where the shot was given -itchy at application site -tiredness (more than usual for being pregnant) -feels hot and hard underneath the skin of application site.
Age: 27.0
Sex: F
Vaccine: TDAP
Symptoms: Injection site pruritus, Injection site swelling, Injection site warmth
Clinical narrative: My pregnancy has been going perfect. Symptoms since the shot -pain where the shot was given -redness and swelling where the shot was given -itchy at application site -tiredness (more than usual for being pregnant) -feels hot and hard underneath the skin of application site.
Age: 3.0
Sex: F
Vaccine: DTAPHEPBIP
Symptoms: Erythema, Hypersensitivity, Nodule, Pain, Skin warm
Clinical narrative: Red, hot, swollen, knot, painful. Iced 15 on 15 off for 1 hour.  Anti inflammatory meds 5ml. 4 inches by 3.5 inches round red spot. Hard painful knot.
Age: 1.0
Sex: M
Vaccine: MMR
Symptoms: Diet refusal, Irritability, Lacrimation increased, Lethargy, Pyrexia
Clinical narrative: 3 weeks after the shot a fever of 100-102 when taken under the arm. At one point it was 103 under the arm. Lasted 2 days and then a rash formed all over the body that lasted 3 days. Fussy, lethargic, watery eyes, would not eat.
Age: 1.0
Sex: M
Vaccine: MMR
Symptoms: Rash generalised
Clinical narrative: 3 weeks after the shot a fever of 100-102 when taken under the arm. At one point it was 103 under the arm. Lasted 2 days and then a rash formed all over the body that lasted 3 days. Fussy, lethargic, watery eyes, would not eat.
Age: 71.0
Sex: F
Vaccine: PNC13
Symptoms: Dizziness, Headache, Injection site erythema, Injection site induration, Injection site mass
Clinical narrative: Swelling, sore large hard lump, redness at injection site. Headache, dizziness, left arm cramps,  Maliase and nauseated.
Age: 71.0
Sex: F
Vaccine: PNC13
Symptoms: Injection site swelling, Malaise, Muscle spasms, Nausea
Clinical narrative: Swelling, sore large hard lump, redness at injection site. Headache, dizziness, left arm cramps,  Maliase and nauseated.
Age: 1.5
Sex: F
Vaccine: DTAP, HIBV
Symptoms: Cough, Pyrexia, Rhinorrhoea
Clinical narrative: High fever x 3 days followed by runny nose and cough. Treated fever with MOTRIN and was only able to bring it down to 102. Fever finally broke 5/12.
Age: 18.0
Sex: M
Vaccine: HEPA
Symptoms: Electrocardiogram ambulatory, Epistaxis, Head injury, Headache, Loss of consciousness
Clinical narrative: Interviewed patient for Vaccination preparation. Ask if he felt weak, dizzy, light headed, had been sick or had cold or illness recently. Patient said "no" he was feeling fine. Patient was getting Hep-A vaccination as deli employee working at grocery store. Gave patient vaccination in deltoid of left arm.  He said arm hurt, but seemed no more than normal shot. He had just finished working and 8 hour shift so was headed home. I assumed he left although we do prefer they sit for at least 15 minutes, but he said his arm hurt but felt fine otherwise. I went back in pharmacy. Patient went around corner of pharmacy and passed out hitting his head. A customer found him and told management. Management and I interviewed him and comforted him. He had only eaten a bowl a cereal all day, his nose was bleeding slightly, and his head was hurting. An ambulance was called he was taken to hospital stayed over night. Discharged with EKG monitor.
Age: 18.0
Sex: M
Vaccine: HEPA
Symptoms: Pain in extremity
Clinical narrative: Interviewed patient for Vaccination preparation. Ask if he felt weak, dizzy, light headed, had been sick or had cold or illness recently. Patient said "no" he was feeling fine. Patient was getting Hep-A vaccination as deli employee working at grocery store. Gave patient vaccination in deltoid of left arm.  He said arm hurt, but seemed no more than normal shot. He had just finished working and 8 hour shift so was headed home. I assumed he left although we do prefer they sit for at least 15 minutes, but he said his arm hurt but felt fine otherwise. I went back in pharmacy. Patient went around corner of pharmacy and passed out hitting his head. A customer found him and told management. Management and I interviewed him and comforted him. He had only eaten a bowl a cereal all day, his nose was bleeding slightly, and his head was hurting. An ambulance was called he was taken to hospital stayed over night. Discharged with EKG monitor.
Age: 47.0
Sex: F
Vaccine: FLU4
Symptoms: Balance disorder, Bed rest, Dysstasia, Malaise, Vertigo
Clinical narrative: Next morning awoke extremely feeling overall ill. I could not stand on my own and hold my balance. My head was spinning all around. Can not remember other symptoms because loss of balance was the worst but my doctor has other documented.
Age: 33.0
Sex: F
Vaccine: PPV
Symptoms: Asthenia, Cellulitis, Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: Left arm cellulitis. 4cm in area with 3 cm firm nodule in center. + Redness, warmth, tender, and swollen. Temp = 99.9. Pt reported fever and generalized weakness. Treated with KEFLEX. Outcome - To be determined.
Age: 33.0
Sex: F
Vaccine: PPV
Symptoms: Injection site warmth, Pyrexia
Clinical narrative: Left arm cellulitis. 4cm in area with 3 cm firm nodule in center. + Redness, warmth, tender, and swollen. Temp = 99.9. Pt reported fever and generalized weakness. Treated with KEFLEX. Outcome - To be determined.
Age: 61.0
Sex: F
Vaccine: VARZOS
Symptoms: Chills, Rash erythematous, Skin warm
Clinical narrative: Patient has a round red rash the size of a grapefruit, stated it was hot. She is having chills. Advised her to take some ibuprofen and some BENADRYL. Explained this is a side effect and it could last up to a week.
Age: 78.0
Sex: F
Vaccine: PPV
Symptoms: Injection site erythema, Injection site pain, Injection site pruritus, Injection site warmth, Limb discomfort
Clinical narrative: Patient came in on Saturday while I was working, having gotten the vaccination on Friday. Her arm was swollen, red, and hot to the touch, and she wanted me to look at it for her. At that time I recommended BENADRYL, and for her to let me know if it got any worse. I did not see the patient again that day. Sunday morning she came back and her arm did look a bit worse-it was more swollen, and the redness had spread more over her arm versus being more localized. She did also show me some bruising on her arm, although it wasn't near the injection site and she did state she is on blood thinners. She also said it was sore and itchy. I asked her if she had been taking the BENADRYL I recommended yesterday, and she stated she had taken one dose and it seemed to help, but it made her feel very weird. She asked if she could use the cream and I told her it wouldn't be quite as effective, but she could put it on the area to help with the itching, and that it wouldn't make her feel the way that the oral version did since it doesn't get into the system enough (topical). I also recommended some TYLENOL by mouth to help with the soreness. I did advise that she be seen at this point, and she did state that she had an appointment with her PCP, Dr. tomorrow (Monday). I told her to definitely show her arm to the doctor, and to please call me at the pharmacy if it got any worse.
Age: 78.0
Sex: F
Vaccine: PPV
Symptoms: Peripheral swelling
Clinical narrative: Patient came in on Saturday while I was working, having gotten the vaccination on Friday. Her arm was swollen, red, and hot to the touch, and she wanted me to look at it for her. At that time I recommended BENADRYL, and for her to let me know if it got any worse. I did not see the patient again that day. Sunday morning she came back and her arm did look a bit worse-it was more swollen, and the redness had spread more over her arm versus being more localized. She did also show me some bruising on her arm, although it wasn't near the injection site and she did state she is on blood thinners. She also said it was sore and itchy. I asked her if she had been taking the BENADRYL I recommended yesterday, and she stated she had taken one dose and it seemed to help, but it made her feel very weird. She asked if she could use the cream and I told her it wouldn't be quite as effective, but she could put it on the area to help with the itching, and that it wouldn't make her feel the way that the oral version did since it doesn't get into the system enough (topical). I also recommended some TYLENOL by mouth to help with the soreness. I did advise that she be seen at this point, and she did state that she had an appointment with her PCP, Dr. tomorrow (Monday). I told her to definitely show her arm to the doctor, and to please call me at the pharmacy if it got any worse.
Age: 62.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site pain
Clinical narrative: A day + a half later, patient developed a red, tender patch about 1 inch beneath the injection site the size of 1"x3". Patient said the area is just tender and red (not warm nor noticeably swollen).
Age: 68.0
Sex: F
Vaccine: PPV
Symptoms: Chills, Dizziness, Hypersensitivity, Injection site pain, Nausea
Clinical narrative: Received injection 5/1/2018 1700. Awakened next am with extreme pain R deltoid area. By 1600 on 5/2 had chills, shakes and nausea. For the next 2 days I was extremely nauseated, shakes, chills, subjective fevers, only drank 1 glass of water each day. I was dizzy upon sitting or standing and was in bed for these days. On 5/4 I had explosive diarrhea x4 but was able to start sm. amts. fluid. I was able to start solid foods on 5/6. I did report my adverse reaction to Dr. 5/9 and she sent me a reply stating that I had an allergic reaction.
Age: 68.0
Sex: F
Vaccine: PPV
Symptoms: Pyrexia, Tremor
Clinical narrative: Received injection 5/1/2018 1700. Awakened next am with extreme pain R deltoid area. By 1600 on 5/2 had chills, shakes and nausea. For the next 2 days I was extremely nauseated, shakes, chills, subjective fevers, only drank 1 glass of water each day. I was dizzy upon sitting or standing and was in bed for these days. On 5/4 I had explosive diarrhea x4 but was able to start sm. amts. fluid. I was able to start solid foods on 5/6. I did report my adverse reaction to Dr. 5/9 and she sent me a reply stating that I had an allergic reaction.
Age: 74.0
Sex: F
Vaccine: VARZOS, VARZOS, VARZOS, VARZOS
Symptoms: Drooling, Dysarthria, Facial paralysis
Clinical narrative: Patient had left sided Bell's palsy symptoms (slurred speech, droopy of face, saliva coming out of mouth) on 5/6/18. Patient went to Hospital and underwent evaluations by a neurologist who ruled out everything and speculated that it may have been caused by SHINGRIX vaccine.
Age: 74.0
Sex: F
Vaccine: VARZOS, VARZOS, VARZOS, VARZOS
Symptoms: Facial paralysis
Clinical narrative: Patient had left sided Bell's palsy symptoms (slurred speech, droopy of face, saliva coming out of mouth) on 5/6/18. Patient went to Hospital and underwent evaluations by a neurologist who ruled out everything and speculated that it may have been caused by SHINGRIX vaccine.
Age: 74.0
Sex: F
Vaccine: VARZOS, VARZOS, VARZOS, VARZOS
Symptoms: Angiogram normal, Aphasia, Blood test normal, Computerised tomogram normal, Discomfort
Clinical narrative: Patient had left sided Bell's palsy symptoms (slurred speech, droopy of face, saliva coming out of mouth) on 5/6/18. Patient went to Hospital and underwent evaluations by a neurologist who ruled out everything and speculated that it may have been caused by SHINGRIX vaccine.